Is there any role for topical DHT antagonists, or does a 5-AR inhibitor remove the need for them as therapy
    Research/Science 1/6/2025

    At a glance
    In this question or advice post, the primary subjects mentioned are
    ๐Ÿ’Š Finasteride (oral)
    ๐Ÿ’Š Dutasteride (oral)
    ๐Ÿ’ง Topilutamide (topical)
    ๐Ÿ’ง Clascoterone (topical)
    ๐Ÿ’ง Bicalutamide (topical)
    ๐Ÿ’ง Ketoconazole (topical)
    the tone is ๐Ÿ˜ neutral.

    Other terms

    Topical androgen receptor antagonists may not be necessary if 5-AR inhibitors like finasteride or dutasteride effectively reduce DHT levels. Combining a 5-AR inhibitor with a topical androgen antagonist could potentially enhance treatment, but oral use of androgen antagonists is too risky due to severe side effects.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.